With combined scientific research experience in fields ranging from nanochemistry to radiation oncology; and degrees in medicine, neuroscience, biochemistry, microbiology, engineering, and business – the SiNON Therapeutics team is well poised to tackle the challenges. Our small size makes us nimble and responsive, while our experience gives us the ability to execute and exceed expectations.
Founder & CEO
Afreen Allam a recent MBA graduate of Duke’s Fuqua School of Business, has over 7 years of research in nanomedicine. Her background is in Microbiology and Biochemistry. Her extensive studies on applications of carbon nanotechnology in drug delivery and bio-imaging led to the patent of the Carbon Dot in 2013.
Dr. Jeremy Petranka
Petranka comes from a background in Consulting (Has worked for multiple fortune 500 companies) and strategy roles. He has helped companies to align their Information Technology with their Business Strategies.
Lead PhD Researcher
Is responsible to conduct innovative synthesis, purification and solubilization of Carbon Nano particulates based on sizes. He has studied Taxol – Nano Carbon Conjugation.
Dr. Tage Honore
Holds a Masters in Pharmacy, Doctoral Degrees in Medicinal Chemistry and Neurobiology. He’s also had business training from Harvard Business School and European Management Center.
Dr. Jon Fjeld
Jon Fjeld is currently the Executive Direction for The Center Of Entrepreneurship and Innovation at Duke. He has been teaching courses in Entrepreneurship And Strategy at Fuqua since 2005. Fjeld obtained his MA and PhD from The University Of Toronto and his MBA at Duke University.
Duke MBA class of 2007, is the former owner of Grassroots Biotechnology. He successfully sold his company, Grassroots, to Monsanto. Before that, he grew the company to 25 employees with over $4 million in revenue.
Dr Sameer Berry
Sameer Berry MD, MBA is a resident physician and clinical investigator at Cedars-Sinai Medical Center in Los Angeles, CA. He has published numerous articles across oncology, immunology, and gastrointestinal disease. Sameer has been awarded funding for his research through the Society for Interventional Radiology and the Crohn's & Colitis Foundation. At SiNON, Sameer assists with reviewing grant applications and providing clinical strategy for our patented technology.
David Robinson is a professor of finance and the J. Rex Fuqua Distinguished Professor of International Management at the Fuqua School of Business. He is also a faculty research associate at the National Bureau of Economic Research. He earned his doctorate and MBA at the University of Chicago and earned a master of science in economics from the London School of Economics. He is an expert in corporate finance and entrepreneurial finance.
Dr Kenneth Zeitler
Dr Zeitler got his bachelors degree from Columbia College in 1971. MD degree also from Columbia College of Physicians and Surgeons in 1975. Dr Zeitler completed his internship and medical residency at Harvard’s New England Deaconess Hospital until 1978. He has completed his fellowship in Hematology/Oncology at UNC and added a fellowship in Clinical Coagulation finished in 1981. Dr Zeitler is certified in Internal Medicine, Hematology and Medical Oncology. He has held positions of Clinical Assistant and Associate Professor at UNC in the past.